U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Check the time stamp on this data. Updated AI-Generated Signals for Hims & Hers Health Inc. Class A (HIMS) available here: ...

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...

Whether you're cycling the streets or on a stationary bike, cycling is great aerobic exercise. Not all research agrees, but ...

This health news summary covers significant topics including UnitedHealth tech unit's post-hack customer situation, new ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Buy rating on Progyny (PGNY – Research Report). The ...

Hey what gives! That's what we imagine an orange cat was thinking after his owner stopped petting him recently. He was ...

Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.

D Molecular Therapeutics (NASDAQ:FDMT) stock is trading lower on Thursday after the company released interim follow-up data ...

The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...

As the U.S. stock market reaches record highs, driven by a significant rate cut from the Federal Reserve, investors are ...

Minoxidil is one of the most commonly used hair loss treatments — and for good reason. Simply put, it works. But if you’ve ...